Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1233397 | 1.00 | DRD3 (0.30) | DRD3 | |
| SCHEMBL1828412 | 0.79 | — | — | |
| SCHEMBL29946367 | 0.77 | PDK1 (0.41) | DRD3 | |
| SCHEMBL3665971 | 0.77 | DRD3 (0.30) | DRD3 | |
| SCHEMBL3844104 | 0.77 | DRD3 (0.30) | DRD3 | |
| SCHEMBL28976304 | 0.77 | PDK1 (0.41) | DRD3 | |
| SCHEMBL6868438 | 0.77 | DRD3 (0.30) | DRD3 | |
| SCHEMBL15820207 | 0.77 | DRD3 (0.33) | DRD3 | |
| SCHEMBL4447538 | 0.77 | DRD3 (0.30) | DRD3 | |
| Hydrochloric Acid SCHEMBL25293658 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023070064-A1 | O-GLCNACASE (OGA) INHIBITOR COMBINATION THERAPY | ELI LILLY AND COMPANY (US) | 2023-04-27 | — | — | WO | disclosed |
| EP-3829634-A1 | COMBINATION THERAPY | Eli Lilly and Company (US) | 2021-06-09 | — | — | EP | disclosed |
| EP-3630755-A1 | 5-METHYL-1,3,4-OXADIAZOL-2-YL COMPOUNDS | Eli Lilly and Company (US) | 2020-04-08 | — | — | EP | disclosed |
| WO-2020028141-A1 | COMBINATION THERAPY | ELI LILLY AND COMPANY (US) | 2020-02-06 | — | — | WO | disclosed |
| WO-2018217558-A1 | 5-METHYL-1,3,4-OXADIAZOL-2-YL COMPOUNDS | ELI LILLY AND COMPANY (US) | 2018-11-29 | — | — | WO | disclosed |